Literature DB >> 23863741

[A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].

Motoki Sassa1, Yusuke Kobayashi, Hidekazu Sugeno, Manabu Iwadate, Satoshi Suzuki, Yoshiyuki Endo, Izumi Nakamura, Shinji Ohki, Seiichi Takenoshita.   

Abstract

A 64-year-old male patient was diagnosed with rectal gastrointestinal stromal tumor(GIST)by prostate biopsy, because of high PSA. We considered that a radical operation was impossible because the tumor occupied the pelvis, and we suspected prostate invasion. After neoadjuvant chemotherapy(imatinib mesylate 400 mg/day), the tumor size was reduced(90×85 mm→60×50mm), and we could thus perform radical resection. The patient is currently receiving adjuvant chemotherapy (imatinib mesylate 400 mg/day), without recurrence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863741

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.

Authors:  Syed Asif; Nikhil Gupta; Gurudutt Gupta; Anurag Mehta; Shivendra Singh
Journal:  J Gastrointest Cancer       Date:  2017-06

2.  Diagnosis and treatment of gastrointestinal stromal tumor extending to prostate: A case report and literature review.

Authors:  Huan Xu; Chong Liu; Yanbo Chen; Meng Gu; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.